Lakewood-Amedex Biotherapeutics Inc. (LABT)
About Lakewood-Amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$923.3K
- Total assets
- $196.3K
- Market cap
- $9.6M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $9.6M
- Shares outstanding
- 3.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 23, 2026
Lakewood-Amedex Biotherapeutics Inc. (LABT) Stock Price
- Reported a net loss of $923.3K.
- Trading 97% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Lakewood-Amedex Biotherapeutics Inc..
Write a review
Lakewood-Amedex Biotherapeutics Inc.: frequently asked questions
Is Lakewood-Amedex Biotherapeutics Inc. an American company?
Lakewood-Amedex Biotherapeutics Inc. is a US-based company headquartered in University Park, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Lakewood-Amedex Biotherapeutics Inc. headquartered?
Lakewood-Amedex Biotherapeutics Inc. is headquartered in University Park, Florida, United States.
Is Lakewood-Amedex Biotherapeutics Inc. publicly traded?
Yes — Lakewood-Amedex Biotherapeutics Inc. is a publicly traded company. Its stock trades under the ticker symbol LABT on the NASDAQ.
What does Lakewood-Amedex Biotherapeutics Inc. do?
Lakewood-Amedex Biotherapeutics Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
